Cargando…
Acromegaly: the disease, its impact on patients, and managing the burden of long-term treatment
Acromegaly is a rare disease most often caused by the prolonged secretion of excess growth hormone from a pituitary adenoma. The disease is associated with multiple significant comorbidities and increased mortality. The delay to diagnosis is often long. This may be because of low disease awareness a...
Autores principales: | Adelman, Daphne T, Liebert, Karen JP, Nachtigall, Lisa B, Lamerson, Michele, Bakker, Bert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3555549/ https://www.ncbi.nlm.nih.gov/pubmed/23359786 http://dx.doi.org/10.2147/IJGM.S38594 |
Ejemplares similares
-
Changes in Quality of Life After Long-Term Biochemical Control of Acromegaly
por: Kimball, Allison, et al.
Publicado: (2021) -
The endocrine tumor summit 2008: appraising therapeutic approaches for acromegaly and carcinoid syndrome
por: Klibanski, Anne, et al.
Publicado: (2009) -
The Pharmacological Burden of Comorbidities in Acromegaly
por: Fleseriu, Maria, et al.
Publicado: (2021) -
Management of acromegaly
por: Vasilev, Vladimir, et al.
Publicado: (2010) -
Clinical MEN-1 Among a Large Cohort of Patients With Acromegaly
por: Nachtigall, Lisa B, et al.
Publicado: (2020)